Biopersistence and potential adverse health impacts of fibrous nanomaterials: what have we learned from asbestos? by Sanchez, Vanesa C., Pietruska, Jodie R., Miselis, Nathan R., Hurt, Robert H., Kane, Agnes B.

Get full text

Targeting tumor-associated macrophages in an orthotopic murine model of diffuse malignant mesothelioma by Miselis, Nathan R, Wu, Zhijin J, Van Rooijen, Nico, Kane, Agnes B

Get full text

Unique functions of CHK1 and WEE1 underlie synergistic anti-tumor activity upon pharmacologic inhibition by Guertin, Amy D, Martin, Melissa M, Roberts, Brian, Hurd, Melissa, Qu, Xianlu, Miselis, Nathan R, Liu, Yaping, Li, Jing, Feldman, Igor, Benita, Yair, Bloecher, Andrew, Toniatti, Carlo, Shumway, Stuart D

Get full text

Final outcomes analysis of the cell product SQZ‐PBMC‐HPV Phase 1 trial in incurable HPV16+ solid tumors shows improved overall survival in patients with increased CD8+ T cell tumor... by Weaver, Alice N., Iams, Wade T., Park, Jong Chul, Mita, Monica, Holtick, Udo, Gordon, Michael S., Rodabaugh, Kerry J., Dhani, Neesha, Neupane, Prakash, Taylor, Matthew, Amanda Duvall, E., Jennings, Julia, Miselis, Nathan R., Loughhead, Scott, Warren, Marshelle S., Bernstein, Howard, Klussmann, Jens P., Baranda, Joaquina, Jimeno, Antonio

Get full text

Phase 1 study to determine the safety and dosing of autologous PBMCs modified to present HPV16 antigens (SQZ-PBMC-HPV) in HLA-A02+ patients with HPV16+ solid tumors by Jimeno, Antonio, Baranda, Joaquina, Iams, Wade T., Park, Jong Chul, Mita, Monica, Gordon, Michael S., Taylor, Matthew, Dhani, Neesha, Leal, Alexis D., Neupane, Prakash, Eng, Cathy, Yeku, Oladapo, Mita, Alain, Moser, Justin C., Butler, Marcus, Loughhead, Scott M., Jennings, Julia, Miselis, Nathan R., Ji, Rui-Ru, Nair, Nitya, Kornacker, Martin, Zwirtes, Ricardo F., Bernstein, Howard, Sharei, Armon

Get full text

Development of MK-8353, an orally administered ERK1/2 inhibitor, in patients with advanced solid tumors by Moschos, Stergios J, Sullivan, Ryan J, Hwu, Wen-Jen, Ramanathan, Ramesh K, Adjei, Alex A, Fong, Peter C, Shapira-Frommer, Ronnie, Tawbi, Hussein A, Rubino, Joseph, Rush, 3rd, Thomas S, Zhang, Da, Miselis, Nathan R, Samatar, Ahmed A, Chun, Patrick, Rubin, Eric H, Schiller, James, Long, Brian J, Dayananth, Priya, Carr, Donna, Kirschmeier, Paul, Bishop, W Robert, Deng, Yongqi, Cooper, Alan, Shipps, Gerald W, Moreno, Blanca Homet, Robert, Lidia, Ribas, Antoni, Flaherty, Keith T

Get full text

Kinetics of Host Cell Recruitment During Dissemination of Diffuse Malignant Peritoneal Mesothelioma by Miselis, Nathan R., Lau, Bonnie W., Wu, Zhijin, Kane, Agnes B.

Get full text

Abstract 577: Antagonism of the co-inhibitory receptor BTLA enhances efficacy of anti-PD-1 treatment in murine syngeneic tumor models by Miselis, Nathan R., Linn, Douglas, Restaino, Clifford, Baral, Toya, Xia, Jane, Ueda, Roanna, Sawant, Anandi, Baker, Jeanne, Raghunathan, Gopalan, Wang1, Xinzhong, Bowman, Edward, Sukumar, Selvakumar

Get full text

Efficient Repair of All Types of Single-Base Mismatches in Recombination Intermediates in Chinese Hamster Ovary Cells: Competition Between Long-Patch and G-T Glycosylase-Mediated R... by Bill, Colin A, Duran, Walter A, Miselis, Nathan R, Nickoloff, Jac A

Get full text

Abstract 2051: Inhibitors against CHK1 and WEE1, MK-8776 and MK-1775, strongly synergize in vitro and in vivo to inhibit tumor growth by Shumway, Stuart D., Guertin, Amy D., Martin, Melissa M., Roberts, Brian, Hurd, Melissa S., Qu, Xianlu, Miselis, Nathan R., Bloecher, Andrew, Toniatti, Carlo

Get full text

A role for p53 in DNA end rejoining by human cell extracts by BILL, C. A, YU, Y, MISELIS, N. R, LITTLE, J. B, NICKOLOFF, J. A

Get full text